CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Positive Affect Treatment +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05203861
NCT05203861N/ACompleted

Reward and Threat Sensitivity as Mediators of Positive and Negative Affect Treatment

University of California, Los Angeles·interventional·Posted Jan 24, 2022·Updated Apr 25, 2025

In Brief

A clinical study evaluating Positive Affect Treatment and Negative Affect Treatment for Depression and Anxiety. Completed, enrolled 100 participants across 2 sites.

Detailed Summary

The purpose of this study is to evaluate the efficacy and mediators of change in Positive Affect Treatment, a psychotherapy specifically aimed at enhancing reward sensitivity in individuals with low positive affect (a core feature of anhedonia) in the context of depression or anxiety. Target enrollment is 100 male and female participants with low positive affect and depression or anxiety and impaired functioning, between the ages of 18 and 65 years, who will be randomized to either Positive Affect Treatment or Negative Affect Treatment (designed to reduce threat sensitivity). Participants will complete laboratory tests, psychiatric assessments, and self-report questionnaires as part of the study. The total length of participation is around 5 months.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression, Anxiety
CountriesUnited States

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJan 24, 2022
Enrollment StartNov 22, 2021
Primary CompletionMay 31, 2024
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 4.4 years ago

Interventions

Positive Affect Treatmentbehavioral

Sessions 1-7: Pleasurable activities + imaginal recounting and reinforcement of positive mood effects (continued for sessions 8-15) Sessions 8-10: Cognitive exercises focusing on identifying positive aspects of experience, taking responsibility for positive outcomes, and imagining future positive events Sessions 11-14: Exercises to cultivate and savor positive experiences Session 15: Relapse prevention.

Negative Affect Treatmentbehavioral

Sessions 1-7: Exposure therapy to feared or avoided situations, sensations, or memories (continued for sessions 8-15) Sessions 8-10: Cognitive restructuring of probability, cost, and attributional biases Sessions 11-14: Capnometry-assisted respiratory training Session 15: Relapse prevention